Prevalencia de trastornos metabólicos en pacientes VIH positivo con tratamiento antirretroviral en el Hospital Teodoro Maldonado Carbo de la ciudad de Guayaquil en el período 2017 - 2019.

Abstract

HIV/AIDS is an infectious disease, considered to be high risk if the appropriate procedure is not carried out to reduce the viral load, the pharmacological treatment helps to increase the quality of life of the patients, however, it affects the alteration of the metabolic disorders, thus producing a deterioration of the subject and an increase in the cost of the treatment. The study had a quantitative approach, with a non-experimental, descriptive, cross-sectional, and retrospective observational design. The sample analyzed was 618 patients in the Hospital "Teodoro Maldonado Carbo" in the city of Guayaquil, considering the inclusion and exclusion criteria. Of the total number of patients, 279 were between the ages of 40 and 59 years, being the range with the greatest coverage, it was observed that 94.2 % of the total patients were not referred to nutritional consultation despite the fact that their biochemical tests showed alterations in cholesterol, triglycerides and glucose. On the other hand, the most used TAR is TDF 300mg/ FTC200 mg + EFV 600mg being this one of low metabolic impact and mitochondrial toxicity, it should also be taken into account that the treatment with TDF 300mg/ FTC 200mg + LPV 200mg / RTV 50mg is the fifth most used in spite of its higher metabolic impact and mitochondrial toxicity.